skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Treatment of addiction and addiction-related behavior

Abstract

The present invention relates to the use of a composition that increases central nervous system GABA levels in a mammal, for the treatment of addiction to drugs of abuse and modification of behavior associated with addiction to drugs of abuse in said mammal.

Inventors:
; ;
Publication Date:
Research Org.:
Brookhaven National Laboratory (BNL), Upton, NY (United States)
Sponsoring Org.:
USDOE
OSTI Identifier:
1175351
Patent Number(s):
6,890,951
Application Number:
09/933,157
Assignee:
Brookhaven Science Associates LLC (Upton, NY)
DOE Contract Number:  
AC02-98CH10886
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
60 APPLIED LIFE SCIENCES

Citation Formats

Dewey, Stephen L., Brodie, Jonathan D., and Ashby, Jr., Charles R. Treatment of addiction and addiction-related behavior. United States: N. p., 2005. Web.
Dewey, Stephen L., Brodie, Jonathan D., & Ashby, Jr., Charles R. Treatment of addiction and addiction-related behavior. United States.
Dewey, Stephen L., Brodie, Jonathan D., and Ashby, Jr., Charles R. 2005. "Treatment of addiction and addiction-related behavior". United States. https://www.osti.gov/servlets/purl/1175351.
@article{osti_1175351,
title = {Treatment of addiction and addiction-related behavior},
author = {Dewey, Stephen L. and Brodie, Jonathan D. and Ashby, Jr., Charles R.},
abstractNote = {The present invention relates to the use of a composition that increases central nervous system GABA levels in a mammal, for the treatment of addiction to drugs of abuse and modification of behavior associated with addiction to drugs of abuse in said mammal.},
doi = {},
url = {https://www.osti.gov/biblio/1175351}, journal = {},
number = ,
volume = ,
place = {United States},
year = {Tue May 10 00:00:00 EDT 2005},
month = {Tue May 10 00:00:00 EDT 2005}
}

Works referenced in this record:

Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure
journal, June 1997


Conditioned place preference induced by Δ9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward
journal, May 1995


Striatal binding of the PET ligand11C-raclopride is altered by drugs that modify synaptic dopamine levels
journal, April 1993


Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
journal, December 1993


Pharmacologic characterization of nicotine-induced conditioned place preference
journal, February 1985


Nicotine Dependence, Midbrain Dopamine Systems and Psychiatric Disorders
journal, March 1995


Self-administration in rats allowed unlimited access to nicotine
journal, October 1997


Infusion of Nicotine in the Ventral Tegmental Area or the Nucleus Accumbens of the Rat Differentially Affects Accumbal Dopamine Release
journal, December 1994


Cocaine reward models: Conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice
journal, June 1998


Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens
journal, September 1989


Apparent absence of nicotine-induced conditioned place preference in rats
journal, May 1987


Control of behavior by intravenous nicotine injections in human subjects
journal, December 1983


Place Conditioning: A Simple and Effective Method for Assessing the Motivational Properties of Drugs
book, January 1987


Imaging endogenous dopamine competition with [11C]raclopride in the human brain
journal, April 1994


Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs
journal, July 1996


On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones.
journal, July 1988


Treatment of Cocaine Abuse: Pharmacotherapy
book, September 2007

  • Kleber, Herbert D.
  • Ciba Foundation Symposium 166 ‐ Cocaine: Scientific and Social Dimensions: Cocaine: Scientific and Social Dimensions: Ciba Foundation Symposium 166
  • https://doi.org/10.1002/9780470514245.ch11

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.
journal, July 1988


Basic aspects of GABA-transmission in alcoholism, with particular reference to GABA-transaminase
journal, February 1997


Amphetamine and vigabatrin down regulate aromatic l-amino acid decarboxylase mRNA levels
journal, January 1996


Cigarette smokers self-administer intravenous nicotine
journal, November 1983


Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [ N - 11 C-Methyl]-(−)-Cocaine PET Studies in Human Subjects
journal, September 1990


Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds
journal, October 1997


Pharmacological treatment of tobacco dependence
journal, May 1988


Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats
journal, December 1986


A Comparison of Sustained-Release Bupropion and Placebo for Smoking Cessation
journal, October 1997


Baclofen Attenuates the Reinforcing Effects of Cocaine in Rats
journal, October 1996